Daria A. Butuzova

Ms. Daria A. Butuzova

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MKMaria Kulebyakina
Maria Kulebyakina
NBNataliya Basalova
Nataliya Basalova
DBDaria A. Butuzova
Daria A. Butuzova
MAMikhail Arbatsky
Mikhail Arbatsky
VCVadim Chechekhin
Vadim Chechekhin
AEAnastasia Efimenko
Anastasia Efimenko
Multipotent mesenchymal stromal cells (MSCs) regulate tissue repair through paracrine activity, with secreted proteins being significant contributors. Human tissue repair commonly results in fibrosis, where fibroblast differentiation into myofibroblasts is a major cellular mechanism. MSCs’ paracrine activity can inhibit fibrosis development. We previously demonstrated that the separation of MSC secretome, represented by conditioned medium (CM), into subfractions enriched with extracellular vesicles (EV) or soluble factors (SF) boosts EV and SF antifibrotic effect. This effect is realized through the inhibition of fibroblast-to-myofibroblast differentiation in vitro. To unravel the mechanisms of MSC paracrine effects on fibroblast differentiation, we performed a comparative proteomic analysis of MSC secretome fractions. We found that CM was enriched in NF-κB activators and confirmed via qPCR that CM, but not EV or SF, upregulated NF-κB target genes (COX2, IL6, etc.) in human dermal fibroblasts. Furthermore, we revealed that EV and SF were enriched in TGF-β, Notch, IGF, and Wnt pathway regulators. According to scRNAseq, 11 out of 13 corresponding genes were upregulated in a minor MSC subpopulation disappearing in profibrotic conditions. Thus, protein enrichment of MSC secretome fractions and cellular subpopulation patterns shift the balance in fibroblast-to-myofibroblast differentiation, which should be considered in studies of MSC paracrine effects and the therapeutic use of MSC secretome.

1 February 2025 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
DBDaria A. Butuzova
Daria A. Butuzova
MKMaria A. Kulebyakina
Maria A. Kulebyakina
NBNataliya A. Basalova
Nataliya A. Basalova
AEAnastasia Yu. Efimenko
Anastasia Yu. Efimenko
Fibroblast activation protein alpha (FAPα) is a transmembrane serine peptidase and a well-known marker of activated fibroblasts that are formed during onco- and fibrogenesis and play an important role in the progression of cancer and fibrosis. Identification of FAPα-positive cells is widely used to visualize pathological changes in the stroma in the diagnosis and treatment of cancer diseases. Recent evidence suggests that FAPα itself contributes to the development of tumors and fibrosis-associated diseases through its enzymatic activity and other mechanisms. Various methods for visualization and evaluation of FAPα enzymatic activity are being developed, which are essential for deciphering the role of FAPα in the development of stromal pathologies. Here we discuss current approaches to visualization and regulation of FAPα enzymatic activity.

30 October 2026 in Cell and Tissue Biology
Verified
Journal Article
Closed access
PDF file
DBDaria A. Butuzova
Daria A. Butuzova
MKMaria A. Kulebyakina
Maria A. Kulebyakina
NBNataliya A. Basalova
Nataliya A. Basalova
AEAnastasia Yu. Efimenko
Anastasia Yu. Efimenko
Background: Fibroblast activation protein alpha (FAPα) is a transmembrane serine protease whose expression is markedly upregulated in stromal cells during fibrosis and tumor development. Although FAPα is known to participate in extracellular matrix remodeling, the full repertoire of its potential protein partners and enzymatic substrates in activated fibroblasts remains incompletely characterized. This study aimed to identify proteins that form complexes with FAPα in activated human fibroblasts, to evaluate their substrate status, and to confirm cooperation with integrin signaling. Materials and Methods: Primary human dermal fibroblasts were activated by treatment with TGF-β1 (10 ng/mL, 24 h). Immunoprecipitation of FAPα was performed using two independent antibodies (Cell Signaling and R&D Systems), and specificity was confirmed by Western blotting. Proteins eluted from immunoprecipitates were precipitated with trichloroacetic acid, subjected to trypsin digestion, and analyzed by mass spectrometry on a Q Exactive Plus instrument. Data were processed using the MaxQuant and Perseus software suites. Functional annotation of identified proteins was carried out using GO enrichment analysis. The presence of putative FAPα cleavage sites was assessed bioinformatically. Interactions with integrins β1, αV, and TGFβRII were verified by Western blotting. Results: Immunoprecipitation specificity was confirmed for both antibody types. In two independent replicates, a total of 47 proteins were identified, of which 16 specifically co-precipitated with FAPα. Functional annotation revealed significant enrichment among these proteins for peptidases (chymase, carboxypeptidase D), protease inhibitors (annexin A2), and cell adhesion molecules (tenascin). Cleavage site analysis demonstrated that only ZC3H4 simultaneously contains GP, PPGP, and GPA motifs, whereas carboxypeptidase D contains only the GPA motif. Western blotting confirmed the formation of complexes between FAPα and both integrins β1 and αV, as well as reduced co-precipitation of TGFβRII following cell activation. Conclusions: In this study, we identified 16 potential protein partners of FAPα in activated fibroblasts, among which ZC3H4 emerges as the most likely direct substrate. Cooperation between FAPα and both integrins β1 and αV was experimentally confirmed. Collectively, these findings expand our understanding of the functional role of FAPα and provide a foundation for further investigation into its contribution to the pathogenesis of fibrosis and tumor progression.